Loading…

Methylation of l- trans-2,4-Pyrrolidine Dicarboxylate Converts the Glutamate Transport Inhibitor from a Substrate to a Non-substrate Inhibitor

The 4-methyl analogue of the potent inhibitor of CNS l-glutamate neurotransmitter transporters, l- trans-2,4-PDC, was synthesized via a 1,3-dipolar cycloaddition reaction sequence. The bioassays performed not only exhibit increased potency of the methylated derivative over l- trans-2,4-PDC, but also...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry 2002-11, Vol.10 (11), p.3509-3515
Main Authors: Esslinger, C.Sean, Titus, Jody, Koch, Hans P., Bridges, Richard J., Chamberlin, A.Richard
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The 4-methyl analogue of the potent inhibitor of CNS l-glutamate neurotransmitter transporters, l- trans-2,4-PDC, was synthesized via a 1,3-dipolar cycloaddition reaction sequence. The bioassays performed not only exhibit increased potency of the methylated derivative over l- trans-2,4-PDC, but also exhibit non-substrate properties at the rat forebrain synaptosomal glutamate transporter while the parent l- trans-2,4-PDC exhibits substrate properties. These results support two hypotheses developed for distinguishing the physiological properties of transport inhibitors based on molecular modeling studies, and are reported here. Synthesis and evaluation of a potent glutamate neurotransmitter transport inhibitor.
ISSN:0968-0896
1464-3391
DOI:10.1016/S0968-0896(02)00250-X